vs

Side-by-side financial comparison of NOODLES & Co (NDLS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

NOODLES & Co is the larger business by last-quarter revenue ($122.1M vs $75.5M, roughly 1.6× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -4.1%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-2.8M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -1.2%).

Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

NDLS vs PBYI — Head-to-Head

Bigger by revenue
NDLS
NDLS
1.6× larger
NDLS
$122.1M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+31.9% gap
PBYI
27.7%
-4.1%
NDLS
More free cash flow
PBYI
PBYI
$17.2M more FCF
PBYI
$14.4M
$-2.8M
NDLS
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-1.2%
NDLS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
NDLS
NDLS
PBYI
PBYI
Revenue
$122.1M
$75.5M
Net Profit
$-9.2M
Gross Margin
69.3%
Operating Margin
-5.2%
22.7%
Net Margin
-7.5%
Revenue YoY
-4.1%
27.7%
Net Profit YoY
32.8%
EPS (diluted)
$-0.20
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NDLS
NDLS
PBYI
PBYI
Q4 25
$75.5M
Q3 25
$122.1M
$54.5M
Q2 25
$123.8M
$52.4M
Q1 25
$46.0M
Q4 24
$122.8M
$59.1M
Q3 24
$127.4M
$80.5M
Q2 24
$121.4M
$47.1M
Q1 24
$124.3M
$43.8M
Net Profit
NDLS
NDLS
PBYI
PBYI
Q4 25
Q3 25
$-9.2M
$8.8M
Q2 25
$-9.1M
$5.9M
Q1 25
$3.0M
Q4 24
$-6.8M
Q3 24
$-13.6M
$20.3M
Q2 24
$-6.1M
$-4.5M
Q1 24
$-6.1M
$-4.8M
Gross Margin
NDLS
NDLS
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
NDLS
NDLS
PBYI
PBYI
Q4 25
22.7%
Q3 25
-5.2%
17.6%
Q2 25
-5.2%
12.7%
Q1 25
8.7%
Q4 24
-3.9%
22.6%
Q3 24
-9.0%
27.4%
Q2 24
-3.4%
-4.6%
Q1 24
-3.7%
-5.3%
Net Margin
NDLS
NDLS
PBYI
PBYI
Q4 25
Q3 25
-7.5%
16.2%
Q2 25
-7.3%
11.2%
Q1 25
6.5%
Q4 24
-5.5%
Q3 24
-10.7%
25.2%
Q2 24
-5.1%
-9.6%
Q1 24
-4.9%
-11.0%
EPS (diluted)
NDLS
NDLS
PBYI
PBYI
Q4 25
$0.26
Q3 25
$-0.20
$0.17
Q2 25
$-0.20
$0.12
Q1 25
$0.06
Q4 24
$-0.15
$0.40
Q3 24
$-0.30
$0.41
Q2 24
$-0.14
$-0.09
Q1 24
$-1.64
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NDLS
NDLS
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$4.7M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$-38.9M
$130.3M
Total Assets
$280.6M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NDLS
NDLS
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$4.7M
$94.4M
Q2 25
$1.4M
$96.0M
Q1 25
$93.2M
Q4 24
$3.3M
$101.0M
Q3 24
$1.8M
$96.7M
Q2 24
$1.3M
$96.8M
Q1 24
$3.0M
$107.2M
Total Debt
NDLS
NDLS
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
NDLS
NDLS
PBYI
PBYI
Q4 25
$130.3M
Q3 25
$-38.9M
$115.3M
Q2 25
$-13.9M
$104.7M
Q1 25
$97.1M
Q4 24
$3.7M
$92.1M
Q3 24
$9.6M
$71.1M
Q2 24
$21.9M
$48.5M
Q1 24
$27.2M
$51.0M
Total Assets
NDLS
NDLS
PBYI
PBYI
Q4 25
$216.3M
Q3 25
$280.6M
$202.9M
Q2 25
$319.4M
$194.9M
Q1 25
$196.2M
Q4 24
$340.5M
$213.3M
Q3 24
$346.3M
$220.7M
Q2 24
$360.4M
$205.0M
Q1 24
$368.1M
$214.1M
Debt / Equity
NDLS
NDLS
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NDLS
NDLS
PBYI
PBYI
Operating Cash FlowLast quarter
$4.3M
$14.4M
Free Cash FlowOCF − Capex
$-2.8M
$14.4M
FCF MarginFCF / Revenue
-2.3%
19.1%
Capex IntensityCapex / Revenue
5.8%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.5M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NDLS
NDLS
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$4.3M
$9.7M
Q2 25
$4.0M
$14.1M
Q1 25
$3.6M
Q4 24
$5.8M
$15.6M
Q3 24
$4.7M
$11.0M
Q2 24
$7.0M
$1.0M
Q1 24
$164.0K
$11.2M
Free Cash Flow
NDLS
NDLS
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$-2.8M
$9.7M
Q2 25
$1.1M
$14.1M
Q1 25
$3.6M
Q4 24
$-1.3M
$15.6M
Q3 24
$-4.5M
$11.0M
Q2 24
$-1.6M
$1.0M
Q1 24
$-15.2M
FCF Margin
NDLS
NDLS
PBYI
PBYI
Q4 25
19.1%
Q3 25
-2.3%
17.7%
Q2 25
0.9%
26.8%
Q1 25
7.7%
Q4 24
-1.1%
26.4%
Q3 24
-3.5%
13.7%
Q2 24
-1.4%
2.1%
Q1 24
-12.2%
Capex Intensity
NDLS
NDLS
PBYI
PBYI
Q4 25
0.0%
Q3 25
5.8%
0.0%
Q2 25
2.4%
0.0%
Q1 25
0.1%
Q4 24
5.8%
0.0%
Q3 24
7.2%
0.0%
Q2 24
7.1%
0.0%
Q1 24
12.3%
0.0%
Cash Conversion
NDLS
NDLS
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NDLS
NDLS

Food And Beverage$119.6M98%
Franchise$2.5M2%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons